ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ko Bando
Mark W. Turrentine
Thomas G. Sharp
Laszlo Szekely
John W. Brown
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bando, K.
Right arrow Articles by Brown, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bando, K.
Right arrow Articles by Brown, J. W.

Ann Thorac Surg 1998;66:821-828
© 1998 The Society of Thoracic Surgeons


Original articles: Cardiovascular

Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1

Ko Bando, MDa, Mark W. Turrentine, MDa, Palaniswamy Vijay, PhDa, Thomas G. Sharp, MDa, Yasuo Sekine, MDa, Brian J. Lalone, CCPa, Laszlo Szekely, MDa, John W. Brown, MDa

a Section of Cardiothoracic Surgery, James W. Riley Hospital for Children and Indiana University Medical Center, Indianapolis, Indiana, USA

Address reprint requests to Dr Bando, Section of Cardiothoracic Surgery, Indiana University Medical Center, 545 Barnhill Dr, EM 215, Indianapolis, IN 46202-5123

Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26–28, 1998.

Background. Modified ultrafiltration (MUF) after cardiopulmonary bypass (CPB) in children decreases body water, removes inflammatory mediators, improves hemodynamics, and decreases transfusion requirements. The optimal target population for MUF needs to be defined. This prospective, randomized study attempted to identify the best candidates for MUF during operations for congenital heart disease.

Methods. Informed consent was obtained from 100 consecutive patients with complex congenital heart disease undergoing operations with CPB. They were randomized into a control group (n = 50) of conventional ultrafiltration during bypass and an experimental group using dilutional ultrafiltration during bypass and venovenous modified ultrafiltration after bypass (MUF group, n = 50). Postoperative arterial oxygenation, duration of ventilatory support, transfusion requirements, hematocrit, chest tube output, and time to chest tube removal were compared between the groups stratified by age and weight, CPB technique, existence of preoperative pulmonary hypertension, and diagnosis.

Results. There were no MUF-related complications. In patients with preoperative pulmonary hypertension, MUF significantly improved postoperative oxygenation (445 ± 129 mm Hg versus control: 307 ± 113 mm Hg, p = 0.002), shortened ventilatory support (42.9 ± 29.5 hours versus control: 162.4 ± 131.2 hours, p = 0.0005), decreased blood transfusion (red blood cells: 16.2 ± 18.2 mL/kg versus control: 41.4 ± 27.8 mL/kg, p = 0.01; coagulation factors: 5.3. ± 6.9 mL/kg versus control: 32.3 ± 15.5 mL/kg, p = 0.01), and led to earlier chest tube removal. In neonates (<=30 days), MUF significantly reduced transfusion of coagulation factors (5.4 ± 5.0 mL/kg versus control: 39.9 ± 25.8 mL/kg, p = 0.007), and duration of ventilatory support (59.3 ± 36.2 hours versus 242.1 ± 143.1 hours, p = 0.0009). In patients with prolonged CPB (>120 minutes), MUF significantly reduced the duration of ventilatory support (44.7 ± 37.0 hours versus 128.7 ± 133.4 hours, p = 0.002). No significant differences were observed between MUF and control patients for any parameter in the presence of ventricular septal defect without pulmonary hypertension, tetralogy of Fallot, or aortic stenosis.

Conclusions. Modified ultrafiltration after CPB is safe and decreases the need for homologous blood transfusion, the duration of ventilatory support, and chest tube placement in selected patients with complex congenital heart disease. The optimal use of MUF includes patients with preoperative pulmonary hypertension, neonates, and patients who require prolonged CPB.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Sung, P. W. Park, K.-H. Park, T.-G. Jun, Y. T. Lee, J.-H. Yang, W. S. Kim, and J. Hwang
Is tricuspid valve replacement a catastrophic operation?
Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 825 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yokoyama, S. Takabayashi, T. Komada, K. Onoda, Y. Mitani, H. Iwata, and H. Shimpo
Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 730 - 735.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
W. Osthaus, H Gorler, J Sievers, N Rahe-Meyer, J Optenhofel, T Breymann, G Theilmeier, and R Suempelmann
Bicarbonate-buffered ultrafiltration during pediatric cardiac surgery prevents electrolyte and acid-base balance disturbances
Perfusion, January 1, 2009; 24(1): 19 - 25.
[Abstract] [PDF]


Home page
PerfusionHome page
J. Perez-Vela, E Ruiz-Alonso, F Guillen-Ramirez, M. Garcia-Maellas, E Renes-Carreno, M Cerro-Garcia, J Cortina-Romero, and I Hernandez-Rodriguez
ICU outcomes in adult cardiac surgery patients in relation to ultrafiltration type
Perfusion, March 1, 2008; 23(2): 79 - 87.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. F. Corno
Systemic venous drainage: can we help Newton?
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1044 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. D. Williams, C. Ramamoorthy, L. Chu, G. B. Hammer, K. Kamra, M. G. Boltz, K. Pentcheva, J. P. McCarthy, and V. M. Reddy
Modified and conventional ultrafiltration during pediatric cardiac surgery: Clinical outcomes compared
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1291 - 1298.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
W. M Medlin and J. J Sistino
Cerebral oxygen saturation changes during modified ultrafiltration
Perfusion, November 1, 2006; 21(6): 325 - 328.
[Abstract] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. G Raja, S. Yousufuddin, F. Rasool, A. Nubi, M. Danton, and J. Pollock
Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery.
Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. G Raja and G. D Dreyfus
Modulation of Systemic Inflammatory Response after Cardiac Surgery
Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A.-B. S. Mahmoud, M. S. Burhani, A. A. Hannef, A. A. Jamjoom, I. S. Al-Githmi, and G. M. Baslaim
Effect of Modified Ultrafiltration on Pulmonary Function After Cardiopulmonary Bypass
Chest, November 1, 2005; 128(5): 3447 - 3453.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Riphagen, M. McDougall, S. M. Tibby, N. Alphonso, D. Anderson, C. Austin, A. Durward, and I. A. Murdoch
"Early" Delayed Sternal Closure Following Pediatric Cardiac Surgery
Ann. Thorac. Surg., August 1, 2005; 80(2): 678 - 684.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. A. Rodriguez, M. Ruel, L. Broecker, and G. Cornel
High Flow Rates During Modified Ultrafiltration Decrease Cerebral Blood Flow Velocity and Venous Oxygen Saturation in Infants
Ann. Thorac. Surg., July 1, 2005; 80(1): 22 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. A. Berdat, E. Eichenberger, J. Ebell, J.-P. Pfammatter, M. Pavlovic, C. Zobrist, E. Gygax, U. Nydegger, and T. Carrel
Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1688 - 1696.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M. S Chew
Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?
Perfusion, January 1, 2004; 19(1_suppl): S57 - S60.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. W. Gaynor
Use of ultrafiltration during and after cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S98 - 100.
[Full Text] [PDF]


Home page
PerfusionHome page
M. A Maluf
Modified ultrafiltration in surgical correction of congenital heart disease with cardiopulmonary bypass
Perfusion, January 1, 2003; 18(1_suppl): 61 - 68.
[Abstract] [PDF]


Home page
PerfusionHome page
M. S Chew, V. Brix-Christensen, H. B Ravn, I. Brandslund, E. Ditlevsen, J. Pedersen, K. Hjortholm, O. K Hansen, E. Tunnesen, and V. E Hjortdal
Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study
Perfusion, September 1, 2002; 17(5): 327 - 333.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Lindberg, A. K. Olsson, P. Jogi, and C. Jonmarker
How common is severe pulmonary hypertension after pediatric cardiac surgery?
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. R. Stephenson Jr and J. L. Myers
Pediatric cardiopulmonary bypass
Ann. Thorac. Surg., December 1, 2001; 72(6): 2176 - 2177.
[Full Text] [PDF]


Home page
CirculationHome page
G. B. Luciani, T. Menon, B. Vecchi, S. Auriemma, and A. Mazzucco
Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations: A Prospective, Randomized Clinical Trial
Circulation, September 18, 2001; 104 (2009): I-253 - I-259.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. W. Gaynor
Use of ultrafiltration during and after cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 209 - 211.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. D. Thompson, D. B. McElhinney, P. Findlay, W. Miller-Hance, M. J. Chen, M. Minami, E. Petrossian, A. J. Parry, V. M. Reddy, and F. L. Hanley
A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 220 - 228.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
K. R Glogowski, A. H Stammers, K. S Niimi, K. D Tremain, M. L Muhle, and C. C Trowbridge
The effect of priming techniques of ultrafiltrators on blood rheology: an in vitro evaluation
Perfusion, May 1, 2001; 16(3): 221 - 228.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. T. Verghese
Modified Ultrafiltration in Children
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 98 - 104.
[Abstract] [PDF]


Home page
PerfusionHome page
M. Onoe, T. Magara, Y. Yamamoto, and T. Nojima
Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery
Perfusion, January 1, 2001; 16(1): 37 - 42.
[Abstract] [PDF]


Home page
PerfusionHome page
G. J Myers, R. B Leadon, L. B Mitchell, and D. B Ross
Simple modified ultrafiltration
Perfusion, September 1, 2000; 15(5): 447 - 452.
[Abstract] [PDF]


Home page
NeoReviewsHome page
P. D. Yorgin, A. Belson, and K. V. Lemley
Continuous Renal Replacement Therapy in Neonates and Young Infants
NeoReviews, September 1, 2000; 1(9): e163 - 172.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. T. Keenan, R. Thiagarajan, K. E. Stephens, G. Williams, C. Ramamoorthy, and F. M. Lupinetti
PULMONARY FUNCTION AFTER MODIFIED VENOVENOUS ULTRAFILTRATION IN INFANTS: A PROSPECTIVE, RANDOMIZED TRIAL
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 501 - 505.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas
Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass
Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.